| Developmental and oncogenic programs in H3K27M gliomas dissected by single-cell RNA-seq MG Filbin, I Tirosh, V Hovestadt, MKL Shaw, LE Escalante, ... Science 360 (6386), 331-335, 2018 | 585 | 2018 |
| Resolving medulloblastoma cellular architecture by single-cell genomics V Hovestadt, KS Smith, L Bihannic, MG Filbin, MKL Shaw, A Baumgartner, ... Nature 572 (7767), 74-79, 2019 | 359 | 2019 |
| High frequency of mosaicism among patients with neurofibromatosis type 1 (NF1) with microdeletions caused by somatic recombination of the JJAZ1 gene H Kehrer-Sawatzki, L Kluwe, C Sandig, M Kohn, K Wimmer, U Krammer, ... The American Journal of Human Genetics 75 (3), 410-423, 2004 | 163 | 2004 |
| Antiangiogenic metronomic therapy for children with recurrent embryonal brain tumors A Peyrl, M Chocholous, MW Kieran, AA Azizi, C Prucker, T Czech, ... Pediatric blood & cancer 59 (3), 511-517, 2012 | 153 | 2012 |
| Atypical teratoid rhabdoid tumor: improved long‐term survival with an intensive multimodal therapy and delayed radiotherapy. The Medical University of Vienna Experience 1992–2012 I Slavc, M Chocholous, U Leiss, C Haberler, A Peyrl, AA Azizi, ... Cancer medicine 3 (1), 91-100, 2014 | 138 | 2014 |
| Single-cell RNA-seq reveals cellular hierarchies and impaired developmental trajectories in pediatric ependymoma J Gojo, B Englinger, L Jiang, JM Hübner, MKL Shaw, OA Hack, ... Cancer cell 38 (1), 44-59. e9, 2020 | 128 | 2020 |
| RNA‐based mutation analysis identifies an unusual MSH6 splicing defect and circumvents PMS2 pseudogene interference J Etzler, A Peyrl, A Zatkova, HU Schildhaus, A Ficek, S Merkelbach‐Bruse, ... Human mutation 29 (2), 299-305, 2008 | 95 | 2008 |
| Aberrant expression of signaling‐related proteins 14‐3‐3 gamma and RACK1 in fetal Down Syndrome brain (trisomy 21) A Peyrl, R Weitzdoerfer, T Gulesserian, M Fountoulakis, G Lubec Electrophoresis 23 (1), 152-157, 2002 | 77 | 2002 |
| Safety of Ommaya reservoirs in children with brain tumors: a 20-year experience with 5472 intraventricular drug administrations in 98 patients A Peyrl, M Chocholous, AA Azizi, T Czech, C Dorfer, D Mitteregger, J Gojo, ... Journal of neuro-oncology 120, 139-145, 2014 | 73 | 2014 |
| Protein profiles of medulloblastoma cell lines DAOY and D283: Identification of tumor‐related proteins and principles A Peyrl, K Krapfenbauer, I Slavc, JW Yang, T Strobel, G Lubec Proteomics 3 (9), 1781-1800, 2003 | 65 | 2003 |
| Personalized treatment of H3K27M-mutant pediatric diffuse gliomas provides improved therapeutic opportunities J Gojo, Z Pavelka, D Zapletalova, MT Schmook, L Mayr, S Madlener, ... Frontiers in Oncology 9, 1436, 2020 | 54 | 2020 |
| Moving forward with metronomic chemotherapy: meeting report of the 2nd International Workshop on Metronomic and Anti-Angiogenic Chemotherapy in Paediatric Oncology E Pasquier, MW Kieran, J Sterba, Y Shaked, S Baruchel, O Oberlin, ... Translational oncology 4 (4), 203-211, 2011 | 51 | 2011 |
| Laser ablation-inductively coupled plasma time-of-flight mass spectrometry imaging of trace elements at the single-cell level for clinical practice S Theiner, A Schweikert, SJM Van Malderen, A Schoeberl, S Neumayer, ... Analytical chemistry 91 (13), 8207-8212, 2019 | 48 | 2019 |
| Monitoring of plexiform neurofibroma in children and adolescents with neurofibromatosis type 1 by [18F]FDG‐PET imaging. Is it of value in asymptomatic patients? AA Azizi, I Slavc, BE Theisen, I Rausch, M Weber, W Happak, O Aszmann, ... Pediatric Blood & Cancer 65 (1), e26733, 2018 | 46 | 2018 |
| Feasibility and tolerability of bevacizumab in children with primary CNS tumors B Reismüller, AA Azizi, A Peyrl, M Heinrich, M Gruber‐Olipitz, D Luckner, ... Pediatric blood & cancer 54 (5), 681-686, 2010 | 46 | 2010 |
| Pharmacokinetics and safety of intrathecal liposomal cytarabine in children aged< 3 years A Peyrl, R Sauermann, F Traunmueller, AA Azizi, M Gruber-Olipitz, ... Clinical pharmacokinetics 48, 265-271, 2009 | 44 | 2009 |
| Cerebrospinal fluid penetration of targeted therapeutics in pediatric brain tumor patients AS Guntner, A Peyrl, L Mayr, B Englinger, W Berger, I Slavc, ... Acta neuropathologica communications 8, 1-13, 2020 | 43 | 2020 |
| Proteomic characterization of the human cortical neuronal cell line HCN-2 A Peyrl, K Krapfenbauer, I Slavc, T Strobel, G Lubec Journal of Chemical Neuroanatomy 26 (3), 171-178, 2003 | 38 | 2003 |
| Telomerase activation in posterior fossa group A ependymomas is associated with dismal prognosis and chromosome 1q gain J Gojo, D Lötsch, S Spiegl-Kreinecker, KW Pajtler, K Neumayer, P Korbel, ... Neuro-oncology 19 (9), 1183-1194, 2017 | 37 | 2017 |
| Determination of a tumor-promoting microenvironment in recurrent medulloblastoma: a multi-omics study of cerebrospinal fluid B Reichl, L Niederstaetter, T Boegl, B Neuditschko, A Bileck, J Gojo, ... Cancers 12 (6), 1350, 2020 | 36 | 2020 |
